Archive: UCSF’s 11 Most Popular Health and Science Stories of 2019
Browse the stories that most engaged our readers in 2019.
University of California San Francisco
Give to UCSFBrowse the stories that most engaged our readers in 2019.
Children and young adults with pediatric cancer are less likely to be alive five and 10 years following diagnosis if their health insurance is public, compared to those with private insurance.
In a breakthrough with important implications for the future of immunotherapy for breast cancer, UCSF scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs.
Now in its sixth year, the Best Global Universities rankings focus on schools’ academic research and reputation.
Patients increasingly resort to crowdfunding websites to pay medical bills, a new UCSF study finds that online donations are sought for lost wages, child care and even occasionally experimental treatments.
Despite a broad campaign among physician groups to reduce the amount of imaging in medicine, the rates of use of CT, MRI and other scans have continued to increase.
A new web tool spells out for the first time the exposures that more than 6.5 million working women in California face that could increase their risk for breast cancer, including industrial solvents, antimicrobials and phthalates.
We talked with Lydia Zablotska, MD, PhD, about the real-life health impacts from the disaster portrayed in the HBO miniseries.
Using advanced technology, scientists have discovered an autoimmune disease that appears to affect men with testicular cancer.
Today, our understanding of glioma subtypes has expanded to include the molecular and genetic variants that can influence a tumor’s development, prognosis, and response to treatment.
Muscle damage is a common side effect of radiation therapy for cancer treatment, and is made worse because the very stem cells responsible for repairing injured muscles typically bear the brunt of
UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone. Using this
Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that until recently would have been considered untreatable are experiencing
Chemtai Mungo, MD, MPH, is committed to tackling the public health effects of gender inequality and helping to improve cervical cancer screening in Kenya.
Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UCSF has found.
UCSF's Thea Tlsty is a winner of the “Grand Challenge” competition sponsored by Cancer Research UK. Her international team will receive $26 million to uncover how chronic inflammation causes cancer.
In laboratory experiments, UCSF researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach.
The amount of radiation that patients are exposed to from CT scans varies widely between institutions and countries, and is largely due to differences in the technical settings of the scanning machines.
Study, led by UCSF, raises intriguing questions about whether the biology of low-risk prostate cancer in black men is distinct from that of other ethnicities.
From sensory processing disorder to how CRISPR is being explored to bring new treatments to patients, these are the stories that most engaged our readers in 2018.
Anxiety and depression may be leading predictors of conditions ranging from heart disease to headaches, having similar effects as long-established risk factors like smoking and obesity.